Phase I Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With Paclitaxel in Patients With Advanced Cancer
Condition(s):NeoplasmsLast Updated:October 11, 2017Completed
Hide Studies Not Open or Pending
Condition(s):NeoplasmsLast Updated:October 11, 2017Completed
Condition(s):Pleural Effusion, Malignant; Pleural Mesothelioma; Pleural Empyema; Pulmonary Diseases or Conditions; Pleural Neoplasms; Pulmonary Atelectasis; Pleural Diseases; Pericardial Effusion; Mediastinal Lymphadenopathy; Pneumothorax and Air Leak; Hemothorax; PyopneumothoraxLast Updated:October 14, 2021Unknown status
Condition(s):Success Rate Under Segmental Epidural; Post Operative PainLast Updated:August 25, 2016Completed
Condition(s):DeliriumLast Updated:December 12, 2022Completed
Condition(s):Pregnancy RelatedLast Updated:May 8, 2018Completed
Condition(s):Unnecessary Nasogastric Tube; Bowel AnastomosisLast Updated:November 11, 2009Completed
Condition(s):Prostate CancerLast Updated:January 5, 2021Not yet recruiting
Condition(s):Abdominal Neoplasm; Colonic Neoplasm; Mesothelioma; Peritoneal NeoplasmLast Updated:November 18, 2015Completed
Condition(s):HemangiomaLast Updated:October 4, 2018Terminated
Condition(s):Non-Small Cell Lung CancerLast Updated:July 17, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.